GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » Price-to-Free-Cash-Flow

Embecta (Embecta) Price-to-Free-Cash-Flow : 77.31 (As of Jun. 02, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Price-to-Free-Cash-Flow?

As of today (2024-06-02), Embecta's share price is $12.37. Embecta's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.16. Hence, Embecta's Price-to-Free-Cash-Flow Ratio for today is 77.31.

The historical rank and industry rank for Embecta's Price-to-Free-Cash-Flow or its related term are showing as below:

EMBC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.73   Med: 6.03   Max: 90.31
Current: 77.31

During the past 5 years, Embecta's highest Price-to-Free-Cash-Flow Ratio was 90.31. The lowest was 3.73. And the median was 6.03.

EMBC's Price-to-Free-Cash-Flow is ranked worse than
82.83% of 332 companies
in the Medical Devices & Instruments industry
Industry Median: 34.365 vs EMBC: 77.31

Embecta's Free Cash Flow per Share for the three months ended in Mar. 2024 was $0.36. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.16.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Embecta was -92.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -55.40% per year.

During the past 5 years, Embecta's highest 3-Year average Free Cash Flow per Share Growth Rate was -4.10% per year. The lowest was -55.40% per year. And the median was -29.75% per year.


Embecta Price-to-Free-Cash-Flow Historical Data

The historical data trend for Embecta's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Price-to-Free-Cash-Flow Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Free-Cash-Flow
- - - 4.26 21.11

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 17.20 21.11 - 82.94

Competitive Comparison of Embecta's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Embecta's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embecta's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Embecta's Price-to-Free-Cash-Flow falls into.



Embecta Price-to-Free-Cash-Flow Calculation

Embecta's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.37/0.16
=77.31

Embecta's Share Price of today is $12.37.
Embecta's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Embecta  (NAS:EMBC) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Embecta Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Embecta's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (Embecta) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Executives
David F Melcher director 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Devdatt Kurdikar officer: President and CEO ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze officer: Chief Financial Officer ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann officer: SVP, GC, Head Corp. Dev., Secy 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner officer: Chief Human Resources Officer 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar officer: SVP and CHRO C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis officer: SVP, Global Manuf./Sup. Chain C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton director ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Milton Mayo Morris director 2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Brian Capone officer: VP, CAO & Corp. Controller 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson director 3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy director BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy director ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach director C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015

Embecta (Embecta) Headlines